1. Home
  2. EBMT vs AGEN Comparison

EBMT vs AGEN Comparison

Compare EBMT & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Bancorp Montana Inc.

EBMT

Eagle Bancorp Montana Inc.

HOLD

Current Price

$23.25

Market Cap

180.7M

Sector

Finance

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.36

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBMT
AGEN
Founded
1922
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
180.7M
147.4M
IPO Year
2009
1999

Fundamental Metrics

Financial Performance
Metric
EBMT
AGEN
Price
$23.25
$3.36
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$24.00
$14.50
AVG Volume (30 Days)
50.3K
557.3K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
2.55%
N/A
EPS Growth
53.23
100.00
EPS
0.51
1.02
Revenue
N/A
$42,877,086.00
Revenue This Year
N/A
$107.63
Revenue Next Year
$5.00
N/A
P/E Ratio
$45.90
$3.01
Revenue Growth
N/A
89.95
52 Week Low
$15.11
$2.71
52 Week High
$23.95
$7.34

Technical Indicators

Market Signals
Indicator
EBMT
AGEN
Relative Strength Index (RSI) 68.76 49.01
Support Level $21.59 $2.93
Resistance Level $23.69 $3.38
Average True Range (ATR) 0.56 0.22
MACD 0.13 0.01
Stochastic Oscillator 88.84 66.33

Price Performance

Historical Comparison
EBMT
AGEN

About EBMT Eagle Bancorp Montana Inc.

Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: